Rapid and Sensitive Detection of Troponin I in Human Whole Blood Samples by Using Silver Nanoparticle Films and Microwave Heating
Authors:
Open Access
- 1 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (5) , 746-752
Abstract
BACKGROUND: Cardiovascular diseases are among the leading causes of mortality in developed countries. It is widely recognized that troponin I (TnI) can be used for the assessment of a myocardial infarction. METHODS: We investigated the use of the microwave-accelerated and metal-enhanced fluorescence (MA-MEF), a technique based on the combined use of low-power microwave heating, silver nanoparticle films (SNFs), and fluorescence spectroscopy for the detection of TnI from human whole blood samples. SNFs were deposited onto amine-modified glass microscope slides by use of Tollen's reaction scheme and characterized by optical absorption spectroscopy and scanning electron microscopy. The detection of TnI from buffer solutions and human whole blood samples on SNFs was carried out by using fluorescence-based immunoassays at room temperature (control immunoassay, 2 h total assay time) or microwave heating (MA-MEF–based immunoassay, 1 min total assay time). RESULTS: We found that the lower limits of detection for TnI from buffer solutions in the control immunoassay and MA-MEF–based immunoassay were 0.1 μg/L and 0.005 μg/L, respectively. However, we were unable to detect TnI in whole blood samples in the control immunoassays owing to the coagulation of whole blood within 5 min of the incubation step. The use of the MA-MEF technique allowed detection of TnI from whole blood samples in 1 min with a lower detection limit of 0.05 μg/L. CONCLUSIONS: The MA-MEF–based immunoassay is one of the fastest reported quantitative detection methodos for detection of TnI in human whole blood and has low detection limits similar to those obtained with commercially available immunoassays.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (5-K25EB007565-04)
- American Heart Association
This publication has 14 references indexed in Scilit:
- Positive cardiac troponin I and T and chest pain in a patient with iatrogenic hypothyroidism and no coronary artery diseaseInternational Journal of Cardiology, 2007
- Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarkerExpert Review of Molecular Diagnostics, 2006
- Fast and sensitive DNA hybridization assays using microwave-accelerated metal-enhanced fluorescenceBiochemical and Biophysical Research Communications, 2006
- Microwave-Accelerated and Metal-Enhanced Fluorescence Myoglobin Detection on Silvered Surfaces: Potential Application to Myocardial Infarction DiagnosisPlasmonics, 2006
- Microwave-Accelerated Metal-Enhanced Fluorescence (MAMEF): Application to Ultra Fast and Sensitive Clinical AssaysJournal of Fluorescence, 2005
- Microwave-Accelerated Metal-Enhanced Fluorescence: Platform Technology for Ultrafast and Ultrabright AssaysAnalytical Chemistry, 2005
- Microfluidic immunosensor systemsBiosensors and Bioelectronics, 2005
- Metal-enhanced fluorescence: an emerging tool in biotechnologyCurrent Opinion in Biotechnology, 2005
- Diagnostic value of serial measurement of cardiac markers in patients with chest pain: Limited value of adding myoglobin to troponin I for exclusion of myocardial infarctionAmerican Heart Journal, 2004
- Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac DamageClinical Chemistry and Laboratory Medicine (CCLM), 1999